No results for ‘’
Senores Pharmaceuticals Ltd
₹1290
(11.14%)
Wed, 24 Jun 2026, 02:42 am
Health Technology
Pharmaceuticals: Major
24.5KSenores Pharmaceuticals Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 45.82 | 45.80 | 45.80 | 45.78 | 45.77 |
| FII | 3.64 | 3.35 | 4.28 | 3.66 | 4.17 |
| DII | 9.61 | 9.31 | 8.61 | 9.51 | 9.65 |
| Public | 40.93 | 41.54 | 41.31 | 41.05 | 40.40 |
| Government | 0 | 0 | 0 | 0 | 0 |
Senores Pharmaceuticals Ltd Shareholding Pattern
The Senores Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Senores Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Senores Pharmaceuticals Ltd (NSE: SENORES, BSE: 544319) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Senores Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Senores Pharmaceuticals Ltd Shareholding Pattern (Latest)
The latest Senores Pharmaceuticals Ltd shareholding for Mar 2026 is:
- Promoters: 45.82%
- FII: 3.64%
- DII: 9.61%
- Public: 40.93%
- Government: 0%
Promoter holding in Senores Pharmaceuticals Ltd has increased, indicating strong confidence from company promoters.
Senores Pharmaceuticals Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Senores Pharmaceuticals Ltd.
- Mar 2026: 45.82%
- Dec 2025: 45.80%
- Sept 2025: 45.80%
- Jun 2025: 45.78%
- Mar 2025: 45.77%
Promoter stake in Senores Pharmaceuticals Ltd has increased, indicating strong long-term confidence.
Senores Pharmaceuticals Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Senores Pharmaceuticals Ltd.
- Mar 2026: 3.64%
- Dec 2025: 3.35%
- Sept 2025: 4.28%
- Jun 2025: 3.66%
- Mar 2025: 4.17%
FII holding in Senores Pharmaceuticals Ltd has increased recently, indicating rising foreign investor interest.
Senores Pharmaceuticals Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 9.61%
- Dec 2025: 9.31%
- Sept 2025: 8.61%
- Jun 2025: 9.51%
- Mar 2025: 9.65%
DII stake in Senores Pharmaceuticals Ltd has increased over time, indicating growing domestic institutional confidence.
Senores Pharmaceuticals Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 40.93%
- Dec 2025: 41.54%
- Sept 2025: 41.31%
- Jun 2025: 41.05%
- Mar 2025: 40.40%
Public holding remains stable with consistent retail participation.
Senores Pharmaceuticals Ltd Government Holding
Government holding in Senores Pharmaceuticals Ltd currently stands at 0%.
Senores Pharmaceuticals Ltd operates without significant government ownership.
Senores Pharmaceuticals Ltd Shareholding Analysis Summary
The Senores Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Senores Pharmaceuticals Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Senores Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.